Research Article

Social and Behavioral Risk Marker Clustering Associated with Biological Risk Factors for Coronary Heart Disease: NHANES 2001–2004

Table 2

Associations of individual components of the Sociobehavioral Risk Marker Index (i.e., education, smoking, fruit/vegetable consumption, and physical activity) with biological coronary heart disease risk factors, stratified by sex and adjusted for race/ethnicity and age, NHANES 2001–2004.

Coronary heart disease risk factors
Average systolic blood pressure (mmHg)*Total cholesterol
(mg/dL)
HDL cholesterol
(mg/dL)
Waist circumference
(cm)
Obese
(yes/no)
Diabetes
(yes/no)
95% CI†† 95% CI 95% CI 95% CIOR‡‡95% CIOR95% CI

Females ( = 4,673)
 ≤High school versus >high school1.220.13, 2.320.84−2.24, 3.923.584.83, 2.333.252.33, 4.171.341.18, 1.521.491.21, 1.83
 Smoker versus nonsmoker0.61−0.78, 2.000.77−3.31, 4.865.407.06, 3.75−0.37−1.55, 0.800.990.84, 1.161.250.95, 1.64
 Did not meet versus met fruit and vegetable guidelines2.481.42, 3.55−1.11−4.04, 1.822.503.70, 1.310.35−0.55, 1.251.141.01, 1.291.020.84, 1.23
 Did not meet versus met physical activity guidelines0.41−0.67, 1.491.50−1.46, 4.473.284.89, 2.083.953.05, 4.851.411.24, 1.591.291.06, 1.58
Males ( = 4,305)
 ≤High school versus >high school1.730.71, 2.75−1.08−4.66, 2.501.402.40, 0.41−0.58−1.45, 0.290.940.82, 1.081.040.86, 1.27
 Smoker versus nonsmoker0.92−0.22, 2.051.62−2.75, 5.990.30−0.91, 1.522.493.45, 1.530.710.61, 0.841.060.84, 1.33
 Did not meet versus met fruit and vegetable guidelines0.94−0.05, 1.931.17−2.31, 4.66−0.63−1.59, 0.34−0.28−1.12, 0.560.970.85, 1.111.060.88, 1.28
 Did not meet versus met physical activity guidelines0.23−0.78, 1.24−1.89−5.48, 1.701.432.43, 0.431.050.19, 1.911.090.95, 1.261.351.12, 1.63

Adjusted for hypertension medication use.
Adjusted for cholesterol medication use.
Obesity defined as body mass index ≥30 kg/m2 versus <30 kg/m2.
Defined as self-reported, doctor-diagnosed diabetes; self-reported use of oral glucose-lowering medications; self-reported insulin use; visually confirmed pharmaceutical use of oral glucose-lowering drug and insulin; or fasting plasma glucose ≥126 mg/dL.
**Coefficient for one unit change in the outcome when comparing levels of the social or behavioral risk marker.
††95% confidence interval.
‡‡Odds ratio.